[VIRTUAL] Extended neuroprotective efficacy of ACT-01 in the animal model of lysolecithin induced demyelination in optic nerve (ECTRIMS 2021) - Sep 23, 2021 - Abstract #P711; Pres time: Oct 14, 2021; 12:00 PM - 09:00 PM; Location: ePoster Library; "ACT-01 provides continuous and sustained neuroprotective effects after a short course administration in the animal model of lysolecithin-induced demyelination, thus suggesting long-term benefits after an inflammatory insult of the CNS."
Preclinical • Ocular Inflammation • Ophthalmology • Optic Neuritis • GSK3B • NDRG1
|
|
Prof. Pablo Villoslada; S. Paris
|